pharma news today glp-1 obesity drug What is the pipeline for future medications for obesity? GLP-1s and the Unintended Consequences

The new drugs, which were originally developed to treat diabetes, are targeting the biology that makes weight so hard to lose and keep off: They dial down hunger in the brain, slow gastric emptying, and improve post-meal insulin signaling

Retrieved from Sweeting, A., Wong, J., Murphy, H

mean daily dose 172 mg)

Here is a practical framework: Important: This Decision Requires a Physician No online comparison guide including this one can replace an individualized medical consultation

Glugacon-like peptide-2: broad receptor expression, limited therapeutic effect on intestinal inflammation and novel role in liver regeneration

While this can be an intended effect, it's important not to reduce your intake of essential daily nutrients